# Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients

> **NCT06139536** · PHASE1 · UNKNOWN · sponsor: **Bio-Thera Solutions** · enrollment: 210 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** BAT4706 Injection
- **DRUG:** BAT1308 Injection

## Key facts

- **NCT ID:** NCT06139536
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-06
- **Primary completion:** 2025-12
- **Final completion:** 2026-02
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139536, "Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06139536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*